Synjardy and Synjardy XR

Boehringer Ingelheim and Lilly

Synjardy and Synjardy XR combines Jardiance (empagliflozin) and Metformin. Jardiance lowers blood glucose levels by excreting glucose through the urine. Metformin decreases the glucose production excreted from the liver. Metformin also increases the body’s sensitivity to insulin. Synjardy and Synjardy XR should be taken in the morning, and water consumption should be increased throughout the day. This medication has been shown to aid in cardiovascular risk reduction.


Features


Specs

Generic Name:
Empagliflozin and Metformin
Drug Class:
SGLT-2 inhibitors, Biguanides
Cost:
High
Medication Type:
Oral